Pacific Point Advisors LLC Grows Holdings in The Clorox Company $CLX

Pacific Point Advisors LLC raised its holdings in shares of The Clorox Company (NYSE:CLX) by 2.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,686 shares of the company’s stock after purchasing an additional 259 shares during the quarter. Pacific Point Advisors LLC’s holdings in Clorox were worth $1,163,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. PFG Investments LLC increased its stake in Clorox by 39.7% in the 2nd quarter. PFG Investments LLC now owns 5,802 shares of the company’s stock worth $697,000 after buying an additional 1,648 shares during the period. Albion Financial Group UT increased its position in shares of Clorox by 0.3% during the second quarter. Albion Financial Group UT now owns 34,889 shares of the company’s stock worth $4,189,000 after acquiring an additional 115 shares during the period. V Square Quantitative Management LLC raised its stake in shares of Clorox by 26.4% during the second quarter. V Square Quantitative Management LLC now owns 4,442 shares of the company’s stock valued at $533,000 after acquiring an additional 929 shares in the last quarter. TBH Global Asset Management LLC boosted its holdings in shares of Clorox by 47.2% in the second quarter. TBH Global Asset Management LLC now owns 3,000 shares of the company’s stock valued at $360,000 after purchasing an additional 962 shares during the period. Finally, Brown Lisle Cummings Inc. grew its stake in Clorox by 4.3% in the second quarter. Brown Lisle Cummings Inc. now owns 2,136 shares of the company’s stock worth $256,000 after purchasing an additional 89 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on CLX. Barclays decreased their target price on Clorox from $118.00 to $112.00 and set an “underweight” rating for the company in a research report on Tuesday. Wells Fargo & Company decreased their price objective on Clorox from $130.00 to $125.00 and set an “equal weight” rating for the company in a report on Thursday, September 25th. JPMorgan Chase & Co. increased their target price on shares of Clorox from $133.00 to $135.00 and gave the stock a “neutral” rating in a report on Monday, September 8th. Zacks Research upgraded shares of Clorox from a “strong sell” rating to a “hold” rating in a report on Monday. Finally, UBS Group lowered their price target on shares of Clorox from $150.00 to $134.00 and set a “neutral” rating for the company in a research report on Thursday, July 17th. One equities research analyst has rated the stock with a Buy rating, nine have given a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Reduce” and a consensus price target of $141.09.

Clorox Stock Performance

Shares of Clorox stock opened at $123.32 on Wednesday. The company has a market capitalization of $15.08 billion, a PE ratio of 18.91, a P/E/G ratio of 0.99 and a beta of 0.52. The company has a 50-day simple moving average of $123.33 and a two-hundred day simple moving average of $130.02. The Clorox Company has a one year low of $116.53 and a one year high of $171.37. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The firm had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.94 billion. During the same quarter in the previous year, the firm earned $1.82 EPS. The company’s quarterly revenue was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Research analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be paid a dividend of $1.24 per share. This represents a $4.96 annualized dividend and a yield of 4.0%. The ex-dividend date is Wednesday, October 22nd. Clorox’s payout ratio is 76.07%.

Insider Transactions at Clorox

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the sale, the chief operating officer directly owned 54,221 shares in the company, valued at approximately $6,711,475.38. This trade represents a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.57% of the stock is owned by corporate insiders.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.